Related Experiment Video
Updated: Jun 26, 2025

04:14
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
11.9K
A turning point in hepatology? EASL reflects on the first approved drug for MASH
Sven Francque1, Aleksander Krag2, Debbie L Shawcross3
1Department of Gastroenterology Hepatology, Antwerp University Hospital, Edegem, Belgium; InflaMed Centre of Excellence, Laboratory for Experimental Medicine and Paediatrics, Translational Sciences in Inflammation and Immunology, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
Journal of Hepatology
|May 18, 2024
Abstract
No abstract available in PubMed .

